Ignite Creation Date:
2024-05-06 @ 12:27 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03768531
Status:
WITHDRAWN
Last Update Posted:
2020-04-13
First Post:
2018-12-05
Brief Title:
Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-05
First Submit QC Date:
December 6 2018
Study First Post Date:
2018-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-09
Last Update Post Date:
2020-04-13
Last Update Post Date Type:
ACTUAL